The Bolton Treo Endograft: A Single-Center Preliminary Experience
| Autor: | Maurizio Lovotti, Angelo Argenteri, Enrico Maria Marone, Piernicola Palmieri, Luigi F. Rinaldi |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Treo
Male medicine.medical_specialty Time Factors Endoleak Computed Tomography Angiography Technical success 030204 cardiovascular system & hematology Single Center Prosthesis Design Aortography 030218 nuclear medicine & medical imaging 03 medical and health sciences Blood Vessel Prosthesis Implantation 0302 clinical medicine Risk Factors Medicine Humans Aged business.industry Endovascular Procedures Graft Occlusion Vascular Thrombosis General Medicine High effectiveness medicine.disease Surgery Blood Vessel Prosthesis Perioperative death Treatment Outcome Italy Female Stents Cardiology and Cardiovascular Medicine business Aortic Aneurysm Abdominal |
| Zdroj: | Annals of vascular surgery. 56 |
| ISSN: | 1615-5947 |
| Popis: | Background Endovascular repair is currently the most frequently used treatment of abdominal aortic aneurysms, but its feasibility and success highly depend on the characteristics and the correct choice of the endograft to be used. Bolton Treo is one of the most popular endografts of newer generation which have been launched in the past few years, and this study aims to analyze the preliminary outcomes (8 months in average) of a single-center experience with this device. Methods Thirty-seven consecutive abdominal aortic aneurysms, treated with Treo between June 2016 and December 2017, were followed up every 3, 6, and 12 months, and any kind of endograft-related complications was recorded. Results Technical success was 100%, and no perioperative death (within 30 days) was recorded. Over a mean follow-up period of 8 months, the overall reintervention rate was 5.4% (2 cases, for a type Ia endoleak and an iliac branch thrombosis), for those performed by endovascular techniques. Two type II endoleaks, not worthy of treatment, were also observed. No procedure-related mortality, endograft thrombosis, or rupture was observed. Conclusions Over the short term, Treo demonstrated high effectiveness in treating abdominal aortic aneurysms both in elective and urgent settings, within and outside the indications for use. Outcomes over long term are still needed to validate these results. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|